These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32367340)

  • 61. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
    Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
    PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
    McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
    Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia.
    Strilchuk L; Tocci G; Fogacci F; Cicero AFG
    Expert Opin Pharmacother; 2020 Apr; 21(5):531-539. PubMed ID: 32036729
    [No Abstract]   [Full Text] [Related]  

  • 64. Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial.
    Bonaca MP; Gutierrez JA; Cannon C; Giugliano R; Blazing M; Park JG; White J; Tershakovec A; Braunwald E
    Lancet Diabetes Endocrinol; 2018 Dec; 6(12):934-943. PubMed ID: 30396865
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).
    Otagiri K; Tsutsui H; Kumazaki S; Miyashita Y; Aizawa K; Koshikawa M; Kasai H; Izawa A; Tomita T; Koyama J; Ikeda U
    Circ J; 2011; 75(3):633-41. PubMed ID: 21266787
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
    Quirce R; Martínez-Rodríguez I; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; López-Defilló J; Jiménez-Alonso M; Revilla MA; Carril JM
    Clin Physiol Funct Imaging; 2016 Nov; 36(6):499-503. PubMed ID: 26147617
    [TBL] [Abstract][Full Text] [Related]  

  • 67. NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins.
    Altaf A; Qu P; Zhao Y; Wang H; Lou D; Niu N
    Coron Artery Dis; 2015 Aug; 26(5):409-21. PubMed ID: 25946654
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ezetimibe-Statin Combination Therapy.
    Nußbaumer B; Glechner A; Kaminski-Hartenthaler A; Mahlknecht P; Gartlehner G
    Dtsch Arztebl Int; 2016 Jul; 113(26):445-53. PubMed ID: 27412989
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.
    Murphy SA; Cannon CP; Blazing MA; Giugliano RP; White JA; Lokhnygina Y; Reist C; Im K; Bohula EA; Isaza D; Lopez-Sendon J; Dellborg M; Kher U; Tershakovec AM; Braunwald E
    J Am Coll Cardiol; 2016 Feb; 67(4):353-361. PubMed ID: 26821621
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
    Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
    Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
    Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy.
    Madonna R; Renna FV; Lanuti P; Perfetti M; Marchisio M; Briguori C; Condorelli G; Manzoli L; De Caterina R
    PLoS One; 2017; 12(4):e0172800. PubMed ID: 28394933
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial.
    Almalki ZS; Guo JJ; Alahmari A; Alotaibi N; Thaibah H
    Heart Lung Circ; 2018 Jun; 27(6):656-665. PubMed ID: 28716519
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-.
    Okada K; Kimura K; Iwahashi N; Endo T; Himeno H; Fukui K; Kobayashi S; Shimizu M; Iwasawa Y; Morita Y; Wada A; Shigemasa T; Mochida Y; Shimizu T; Sawada R; Uchino K; Umemura S
    Circ J; 2011; 75(10):2496-504. PubMed ID: 21817821
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cost-effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal.
    Laires PA; Ejzykowicz F; Hsu TY; Ambegaonkar B; Davies G
    J Med Econ; 2015; 18(8):565-72. PubMed ID: 25788039
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome.
    Liu Z; Hao H; Yin C; Chu Y; Li J; Xu D
    Oncotarget; 2017 Jun; 8(25):41582-41589. PubMed ID: 28177908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lipid-Lowering Therapy With Ezetimibe Decreases Spontaneous Atherothrombotic Occlusions in a Rabbit Model of Plaque Erosion: A Role of Serum Oxysterols.
    Honda K; Matoba T; Antoku Y; Koga JI; Ichi I; Nakano K; Tsutsui H; Egashira K
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):757-771. PubMed ID: 29449331
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial.
    Takase S; Matoba T; Nakashiro S; Mukai Y; Inoue S; Oi K; Higo T; Katsuki S; Takemoto M; Suematsu N; Eshima K; Miyata K; Yamamoto M; Usui M; Sadamatsu K; Satoh S; Kadokami T; Hironaga K; Ichi I; Todaka K; Kishimoto J; Egashira K; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):350-358. PubMed ID: 27932353
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy.
    De Ferrari GM; Perna GP; Nicosia A; Guasti L; Casu G; Cuccia C; Picco F; Strazzella C; Totaro R; Cercone S; Canullo L; Horack M; Lautsch D; Gitt AK; Di Biase M
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):485-490. PubMed ID: 29917002
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of ezetimibe-statin combination on steroid hormone production in men with coronary artery disease and low cholesterol levels.
    Krysiak R; Kowalska B; Żmuda W; Okopień B
    Pharmacol Rep; 2015 Apr; 67(2):305-9. PubMed ID: 25712655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.